FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285396641> ?p ?o ?g. }

• W4285396641 abstract "Introduction: Ceftriaxone, a third-generation cephalosporin, is frequently used for the treatment of various bacterial infections as a broad-spectrum antibiotic for many decades. Although ceftriaxone is a well-tolerated drug in most cases, it can lead to serious liver injury, which can be a real challenge to the treating physician. Given the potentially serious adverse effects that can vary from mild biochemical abnormalities to complete liver failure, we intend to assess the spectrum of liver injury based on biochemical criteria for patients treated with ceftriaxone for common bacterial infections in Qatar.Objectives: This study aimed to explore the incidence of ceftriaxone-induced liver injury at Hazm Mebaireek General Hospital, Qatar, and to evaluate the relationship of the ceftriaxone dose, if any, with liver dysfunction.Methods: This retrospective study included hospitalized adult patients treated with ceftriaxone at our hospital from January 2019 to December 2019 and analyzed demographic and clinical data obtained from electronic medical records. This study determined the incidence of liver injury (primary outcome) in patients treated with ceftriaxone (2 g/day) for ≥ 2 consecutive days by reviewing liver function test results until the day of discharge and at the first outpatient follow-up. Results: The final data analysis included a total of 634 patients admitted and treated with ceftriaxone from January 2019 to December 2019.In the multivariate analysis with propensity score adjustment, ceftriaxone was independently associated with liver injury, especially when combined with other agents utilizing hepatic metabolism.Conclusions: Ceftriaxone was associated with a significantly higher incidence of liver injury (19.7%) when used along with other medications that are metabolized in the liver, as found in the present study compared with other similar studies (approximately 2.9%–13.9%). Furthermore, the incidence was too high to be ignored in clinical practice." @default.
• W4285396641 created "2022-07-14" @default.
• W4285396641 creator A5025010825 @default.
• W4285396641 creator A5026676463 @default.
• W4285396641 creator A5035455768 @default.
• W4285396641 creator A5036367153 @default.
• W4285396641 creator A5036973971 @default.
• W4285396641 creator A5045403837 @default.
• W4285396641 creator A5051122579 @default.
• W4285396641 creator A5070877076 @default.
• W4285396641 creator A5074703165 @default.
• W4285396641 creator A5079233407 @default.
• W4285396641 date "2022-09-15" @default.
• W4285396641 modified "2023-10-12" @default.
• W4285396641 title "Ceftriaxone-induced hepatotoxicity in patients with common medical infections in Qatar: A retrospective study" @default.
• W4285396641 cites W1684412556 @default.
• W4285396641 cites W1965088030 @default.
• W4285396641 cites W1966268750 @default.
• W4285396641 cites W1969780974 @default.
• W4285396641 cites W1975440270 @default.
• W4285396641 cites W1976214439 @default.
• W4285396641 cites W1979392432 @default.
• W4285396641 cites W1979893692 @default.
• W4285396641 cites W1981762528 @default.
• W4285396641 cites W1997435071 @default.
• W4285396641 cites W1998416434 @default.
• W4285396641 cites W2003268732 @default.
• W4285396641 cites W2009648599 @default.
• W4285396641 cites W2026969166 @default.
• W4285396641 cites W2032758907 @default.
• W4285396641 cites W2053595725 @default.
• W4285396641 cites W2084256339 @default.
• W4285396641 cites W2087256708 @default.
• W4285396641 cites W2097427535 @default.
• W4285396641 cites W2102136872 @default.
• W4285396641 cites W2106934241 @default.
• W4285396641 cites W2111923125 @default.
• W4285396641 cites W2115651497 @default.
• W4285396641 cites W2116459155 @default.
• W4285396641 cites W2133487993 @default.
• W4285396641 cites W2147129111 @default.
• W4285396641 cites W2165788910 @default.
• W4285396641 cites W2167091437 @default.
• W4285396641 cites W2168467913 @default.
• W4285396641 cites W2169441188 @default.
• W4285396641 cites W2317818937 @default.
• W4285396641 cites W2321993463 @default.
• W4285396641 cites W2606951369 @default.
• W4285396641 cites W2897109701 @default.
• W4285396641 cites W2991137874 @default.
• W4285396641 cites W4205136705 @default.
• W4285396641 cites W977715 @default.
• W4285396641 doi "https://doi.org/10.5339/qmj.2022.27" @default.
• W4285396641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35864919" @default.
• W4285396641 hasPublicationYear "2022" @default.
• W4285396641 type Work @default.
• W4285396641 citedByCount "2" @default.
• W4285396641 countsByYear W42853966412022 @default.
• W4285396641 countsByYear W42853966412023 @default.
• W4285396641 crossrefType "journal-article" @default.
• W4285396641 hasAuthorship W4285396641A5025010825 @default.
• W4285396641 hasAuthorship W4285396641A5026676463 @default.
• W4285396641 hasAuthorship W4285396641A5035455768 @default.
• W4285396641 hasAuthorship W4285396641A5036367153 @default.
• W4285396641 hasAuthorship W4285396641A5036973971 @default.
• W4285396641 hasAuthorship W4285396641A5045403837 @default.
• W4285396641 hasAuthorship W4285396641A5051122579 @default.
• W4285396641 hasAuthorship W4285396641A5070877076 @default.
• W4285396641 hasAuthorship W4285396641A5074703165 @default.
• W4285396641 hasAuthorship W4285396641A5079233407 @default.
• W4285396641 hasBestOaLocation W42853966411 @default.
• W4285396641 hasConcept C120665830 @default.
• W4285396641 hasConcept C121332964 @default.
• W4285396641 hasConcept C126322002 @default.
• W4285396641 hasConcept C141071460 @default.
• W4285396641 hasConcept C167135981 @default.
• W4285396641 hasConcept C195910791 @default.
• W4285396641 hasConcept C2776520383 @default.
• W4285396641 hasConcept C2776637226 @default.
• W4285396641 hasConcept C501593827 @default.
• W4285396641 hasConcept C512861765 @default.
• W4285396641 hasConcept C61511704 @default.
• W4285396641 hasConcept C64778159 @default.
• W4285396641 hasConcept C71924100 @default.
• W4285396641 hasConcept C86803240 @default.
• W4285396641 hasConcept C89423630 @default.
• W4285396641 hasConceptScore W4285396641C120665830 @default.
• W4285396641 hasConceptScore W4285396641C121332964 @default.
• W4285396641 hasConceptScore W4285396641C126322002 @default.
• W4285396641 hasConceptScore W4285396641C141071460 @default.
• W4285396641 hasConceptScore W4285396641C167135981 @default.
• W4285396641 hasConceptScore W4285396641C195910791 @default.
• W4285396641 hasConceptScore W4285396641C2776520383 @default.
• W4285396641 hasConceptScore W4285396641C2776637226 @default.
• W4285396641 hasConceptScore W4285396641C501593827 @default.
• W4285396641 hasConceptScore W4285396641C512861765 @default.
• W4285396641 hasConceptScore W4285396641C61511704 @default.
• W4285396641 hasConceptScore W4285396641C64778159 @default.
• W4285396641 hasConceptScore W4285396641C71924100 @default.
• W4285396641 hasConceptScore W4285396641C86803240 @default.

• next